Adam Savitz
CIK: 0002008707
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Alto Neuroscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Feb 11, 2026ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
124K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
22.5K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
22.5K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
33K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
33K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
123.6K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
123.6K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
73K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
73K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
76K shares- - Jul 3, 2025ANRO
Alto Neuroscience, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
76K shares- - Feb 5, 2025ANRO
Alto Neuroscience, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
76K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 11, 2026 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 124,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 22,481 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 22,481 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 33,008 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 33,008 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 123,645 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 123,645 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 73,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 73,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 76,000 | - | - | Direct |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 76,000 | - | - | Direct |
| Feb 5, 2025 | ANRO Alto Neuroscience, Inc. | Award(A) Employee Stock Option (Right to Buy) | 76,000 | - | - | Direct |
1-12 of 12 transactions
About Savitz Adam
Savitz Adam (SEC CIK 0002008707) files insider reports with the SEC as CHIEF MEDICAL OFFICER of Alto Neuroscience, Inc. (ANRO).
Signal8 holds 3 ownership filings by Savitz Adam, all Form 4s, filed between Feb 7, 2025 and Feb 13, 2026. Those filings report 12 transactions, from Feb 5, 2025 to Feb 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Savitz Adam's filings is in MOUNTAIN VIEW, CA.
Recent filings by Savitz Adam
- Feb 11, 2026: Grant or award of ANRO derivative securities (Form 4, code A).
- Jul 3, 2025: Grant or award of ANRO derivative securities (Form 4, code A).
- Jul 3, 2025: Disposition to issuer transaction of ANRO derivative securities (Form 4, code D).
- Jul 3, 2025: Grant or award of ANRO derivative securities (Form 4, code A).
- Jul 3, 2025: Disposition to issuer transaction of ANRO derivative securities (Form 4, code D).
Other insiders filing for Alto Neuroscience, Inc. (ANRO)
- Smith Nicholas Conrad, PRESIDENT AND CFO
- Miller Andrew Craig, Director
- Etkin Amit, PRESIDENT AND CEO
- Sanchez Ramiro, Director
- Cox Christopher Nixon, Director
- Manji Husseini, Director